/Companies

RYNE Biotechnology Inc.

Cambridge, US · Founded 2022 · Delaware corporation · 2 known investors

Find your way into RYNE Biotechnology Inc.

Sign up to see every warm intro you have to RYNE Biotechnology Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RYNE Biotechnology Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

PF
Peter FuhrkenNamed on SEC filing
HF
Howard FederoffNamed on SEC filing
NM
Nick ManusosNamed on SEC filing
MO
Martin OstrowskiNamed on SEC filing
JY
Jonathan YehNamed on SEC filing

Board

JGJeff Goater
Jeff GoaterBoard directorPartner at The Column Group
DFDavid Fallace
David FallaceBoard directorManaging Partner at Cure Ventures
JJJeff Jonas
Jeff JonasBoard directorPartner at Cure Ventures

Investors · 2

Reported raises · per SEC filings

Form D private placements

$33M disclosed across 2 rounds · 2022–2024

▶$30MraisedMar 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff GoaterDirector
  • Peter FuhrkenDirector
  • Howard FederoffExecutive Officer, Director
  • Nick ManusosExecutive Officer, Director
  • David FallaceDirector
  • Jeff JonasDirector
  • Martin OstrowskiExecutive Officer
  • Jonathan YehDirector
Offering amount
$81.8M
Amount sold
$30M
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard FederoffDirector
  • Jonathan YehExecutive Officer, Director
  • Nick ManusosExecutive Officer, Director
  • Carter CliffDirector
Offering amount
$5M
Amount sold
$3M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through RYNE Biotechnology Inc. went on to found or lead other companies.

Frequently asked questions

Who are RYNE Biotechnology Inc.'s investors?
RYNE Biotechnology Inc.'s investors include Cure Ventures, The Column Group.
How much funding has RYNE Biotechnology Inc. raised?
RYNE Biotechnology Inc. has disclosed $33M raised across 2 rounds.
Where is RYNE Biotechnology Inc. headquartered?
RYNE Biotechnology Inc. is headquartered in Cambridge, US.